title: Volume-regulated arginine vasopressin release in conscious dogs. Evidence for dopaminergic or opioid modulation?
abstract: The possibility of a dopaminergic and/or opioid modulation of the volume-regulated release of AVP was investigated in conscious dogs. Either bromocriptine, 10 micrograms/kg body weight po, or naloxone, 0.1 mg/kg body weight iv, was administered prior to induction of nonhypotensive hypovolemia. Volume contraction of 15 ml/kg body weight was induced gradually, over a period of 30 min. Basal plasma AVP levels in the bromocriptine group were not significantly different from control group values. Bromocriptine administration significantly augmented AVP release following volume contraction. Mean arterial pressure in the bromocriptine group decreased to a slightly, but significantly, lower level than that in the control group. Mean arterial pressures, however, did not adequately explain the magnitude of the AVP response in the bromocriptine group. In the naloxone group, neither baseline levels, nor AVP values following volume contraction, differed significantly from respective control group values. In conclusion, the results suggest the possibility of a stimulatory role for endogenous dopamine in the volume-regulated, but not the basal, release of AVP in conscious dogs.
authors.affiliation: Subdepartment of Veterinary Anesthesia, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.
authors.forename: L J
authors.initials: LJ
authors.lastname: Hellebrekers
authors.forename: E
authors.initials: E
authors.lastname: Lagerweij
authors.forename: H W
authors.initials: HW
authors.lastname: de Vries
authors.forename: T B
authors.initials: TB
authors.lastname: van Wimersma Greidanus
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects*; D001971:Bromocriptine / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects*; D011957:Receptors, Opioid / Q000187:drug effects*
chemical_list: D011954:Receptors, Dopamine; D011957:Receptors, Opioid; D001127:Arginine Vasopressin; D009270:Naloxone; D001971:Bromocriptine